Yitzhak Peterburg, who served as interim president and CEO of Teva from February to November 2017, has resigned from its board, effective immediately. Peterburg had served as chairman of the Board of Directors since Jan. 2015.
According to a company filing, Peterburg's resignation was "solely for personal reasons and does not involve any disagreement with the Company."
Freshly appointed CEO Kare Schultz, who joined the troubled Israeli drugmaker on Nov. 1, has already shaken up the company's division heads in a move to streamline the organization.
Read the Reuters report